Want to see JBIO full AI Analyst Report?
Jade Biosciences (JBIO) Ownership - Who Owns Jade Biosciences?
Jade Biosciences (JBIO) Ownership Overview
- 8.01% Insiders
- 24.08% Mutual Funds
- 0.04% Other Institutional Investors
- 11.31% ETFs
- 56.56% Public Companies and Individual Investors
The ownership structure of Jade Biosciences (JBIO) stock is a mix of institutional, retail, and individual investors. Approximately 35.44% of the company’s stock is owned by Institutional Investors, 8.01% is owned by Insiders, and 56.56% is owned by Public Companies and Individual Investors.
The ownership structure of Jade Biosciences (JBIO) stock is a mix of institutional, retail, and individual investors. Approximately 24.12% of the company’s stock is owned by Institutional Investors, 8.01% is owned by Insiders, and 11.31% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Baker Bros Advisors Lp | $27,340,066 | |
| Jun 30, 2026 | Woodline Partners Lp | $2,227,977 | |
| Jun 30, 2026 | Blackstone Inc. | $9,672,810 | |
| Jun 30, 2026 | Versant Venture Management, Llc | $22,037,418 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fairmount Funds Management Llc | 4,553,494 | Insider | 7.16% | 64,022,126 |
| Peter Harwin | 4,553,494 | Institution | 7.16% | 64,022,126 |
| Peter Kolchinsky | 3,671,083 | Institution | 5.77% | 51,615,427 |
| Vanguard | 2,828,932 | Institution | 4.45% | 39,774,784 |
| Vanguard Index Funds | 2,184,307 | Institution | 3.43% | 30,711,356 |
| Spdr | 1,936,739 | Institution | 3.05% | 27,230,550 |
| Fidelity Mt. Vernon Street Trust | 1,844,814 | Institution | 2.90% | 25,938,085 |
| Fidelity Securities Fund | 1,745,375 | Institution | 2.74% | 24,539,973 |
| Ishares | 1,621,090 | Institution | 2.55% | 22,792,525 |
| Franklin Value Investors Trust | 1,489,641 | Institution | 2.34% | 20,944,352 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 2,184,307 | Institution | 3.43% | 30,711,356 |
| Fidelity Mt. Vernon Street Trust | 1,844,814 | Institution | 2.90% | 25,938,085 |
| Fidelity Securities Fund | 1,745,375 | Institution | 2.74% | 24,539,973 |
| Franklin Value Investors Trust | 1,489,641 | Institution | 2.34% | 20,944,352 |
| Fidelity Select Portfolios | 1,482,450 | Institution | 2.33% | 20,843,247 |
| Fidelity Advisor Series Vii | 1,069,271 | Institution | 1.68% | 15,033,950 |
| Franklin Strategic Series | 912,658 | Institution | 1.44% | 12,831,971 |
| Fidelity Capital Trust | 908,146 | Institution | 1.43% | 12,768,533 |
| Janus Investment Fund | 716,799 | Institution | 1.13% | 10,078,194 |
| Jpmorgan Trust Ii | 677,766 | Institution | 1.07% | 9,529,390 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| SPDR | 1,791,860 | Institution | 2.82% | 25,516,086 |
| Vanguard | 1,699,343 | Institution | 2.67% | 23,875,769 |
| iShares | 1,008,834 | Institution | 1.59% | 14,365,796 |
| Vanguard | 590,285 | Institution | 0.93% | 8,293,504 |
| iShares | 378,342 | Institution | 0.59% | 5,319,489 |
| Schwab | 279,562 | Institution | 0.44% | 3,980,963 |
| Vanguard | 233,679 | Institution | 0.37% | 3,283,190 |
| Vanguard | 130,251 | Institution | 0.20% | 1,830,027 |
| iShares | 121,317 | Institution | 0.19% | 1,727,554 |
| Fidelity | 108,274 | Institution | 0.17% | 2,312,733 |
FAQ
Who Owns Jade Biosciences (JBIO)?
According to the latest TipRanks data, approximately 0.04% of the company's stock is held by institutional investors, 8.01% is held by insiders, and 56.56% is held by retail investors.
What percentage of Jade Biosciences (JBIO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.04% of Jade Biosciences (JBIO) stock is held by institutional investors.
What percentage of Jade Biosciences (JBIO) stock is held by retail investors?
According to the latest TipRanks data, approximately 56.56% of Jade Biosciences (JBIO) stock is held by retail investors.
Who owns the most shares of Jade Biosciences (JBIO)?
Fairmount Funds Management LLC owns the most shares of Jade Biosciences (JBIO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.